Results 111 to 120 of about 8,864 (209)

External dose assessment from the patients treated by 177Lu-DOTATATE

International Journal of Radiation Research, 2022
E. Mahmoudi, M. Amoui, M.R. Deevband, E. Pirayesh, M. Ghorbani Rad   +4 more
openaire   +1 more source

Immunogenic cell death as a mechanism of synergy between sunitinib and ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors. [PDF]

Cell Death Discov
Essler M, Veit N, Müller A, Marinova M, Kreppel B.   +4 more
europepmc   +1 more source

Biological Sex Influences the Pharmacokinetics and Organ Dosimetry of ¹⁷⁷Lu-DOTATATE: A Systematic Preclinical Evaluation. [PDF]

Pharmaceuticals (Basel)
Kong X, Li P, Wang Z, Cai C, Zhang M, Qu C, Jin C, Zhang H, Dong Y, Lv K, Han F.   +10 more
europepmc   +1 more source

Combined SSTR2-targeted Analogue with ¹⁷⁷Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report. [PDF]

Front Oncol
Yuen CA, Jafarvand M, Kamson DO, Chu E, Soun JE, Yong WH, Hsu FP, Bow H, Zheng M, Srinivas SM.   +9 more
europepmc   +1 more source

Expanding the therapeutic horizon of ¹⁷⁷Lu-DOTATATE: a review of current evidence. [PDF]

Nagoya J Med Sci
Minamimoto R, Kato K, Iwano S, Nishii R, Abe Y, Naganawa S.   +5 more
europepmc   +1 more source

Evaluation of segmentation accuracy and the improvement of time effectiveness using deep learning-based segmentation in ¹⁷⁷Lu-DOTATATE dosimetry. [PDF]

EJNMMI Phys
Nakaichi T, Shimizu Y, Nakamura S, Shuto Y, Kasai Y, Shishido A, Kunito K, Nakayama H, Takemori M, Kawamura M, Chiba T, Okamoto H, Kashihara T, Igaki H, Ito K.   +14 more
europepmc   +1 more source

Cumulative Absorbed Dose and Successive Cyclic Reduction in Absorbed Dose Predict Response to ¹⁷⁷Lu-DOTATATE in Neuroendocrine Tumors. [PDF]

J Nucl Med
Macsuka MJ, Driscoll B, Yeung IWT, Publicover J, Metser U, Juergens R, Myrehaug SD, Laidley D, Wong RK, McGowan DR, Vallis KA.   +10 more
europepmc   +1 more source

Quantitative 177Lu-DOTATATE SPECT/CT is predictive of 6-month PRRT morphological response in midgut neuroendocrine tumors: a pilot study. [PDF]

EJNMMI Res
Megherbi I, Hoog C, Perrier M, Brixi H, Cadiot G, Hoeffel-Fornes C, Morland D.   +6 more
europepmc   +1 more source

Toward personalized management of metastatic PPGL: decoding the implications of the ¹⁷⁷Lu-DOTATATE Phase II interim analysis. [PDF]

Int J Surg
Liu T, Ji J, Yan Z.
europepmc   +1 more source

Predicting subacute hematological toxicity of 177Lu-DOTATATE therapy using healthy organs' uptake on post-treatment quantitative SPECT: A pilot study. [PDF]

Medicine (Baltimore), 2022
Morland D, Triumbari EKA, Hoog C, Sézin G, Dejust S, Cadiot G, Paris P, Papathanassiou D.   +7 more
europepmc   +1 more source